Live feed16:05:00·1158dPRReleasevia QuantisnowMyriad Genetics Reports Fourth Quarter Financial Results; Fourth Quarter Revenue of $177.8 Million Grew 11% Year-Over-Year Driven by 16% Growth in Hereditary Cancer Volumes and 23% Growth in GeneSight® VolumesByQuantisnow·Wall Street's wire, on your screen.MYGN· Myriad Genetics Inc.Health Care
